XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa

NEXT STORY
Antibiotic Susceptibility Testing Market will Expand at 5.6% CAGR by 2028- Future Market Insights
PREV STORY
Global Vaccines Market Growth Opportunities – Forecast to 2024 by Production System, Antigens, Procurement System, and End Users
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual

author_avatar
NASDAQ Market News

Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response

author_avatar
NASDAQ Market News

At 6.4% CAGR, Global Nasal Cannula Market to Surpass US$ 10,491.1 Million by 2028, Says Coherent Market Insights (CMI)

author_avatar
NASDAQ Market News